EasyCookieInfo

Harnessing the Immune System
to fight Cancer and Infectious diseases

Help us developing COVID-19 vaccine!

To explore Takis opportunities, click here

https://covid-miner.takisbiotech.it
Click here
Click here

Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine
 

Rome, 27 January 2020 - Takis and Evvivax, two biotechnology companies present in the science park of Castel Romano, Rome announce their commitment for the development of innovative vaccines against 2019-nCoV, the new coronavirus originating in Wuhan, China. To date, the virus has caused 81 deaths and over 2,800 known infections and is rapidly expanding in various countries.

For More information

Rome, 17 March 2020 - Takis, a biotech company in Castel Romano, Rome, announces that it is ready to test its Covid-19 vaccine on pre-clinical models.
 

The authorization comes from the Ministry of Health and represents the first step in bringing the vaccine to human use. Takis researchers are the only ones in Italy and the first in Europe to access this phase of the experimentation.

For More information

Our team
is recognized

for the conception and implementation of a number of innovative technologies with the goal to improve in vivo gene transfer, regulation of gene expression and immunogenicity.

 
Our Company

Takis as a CRO provides a variety of research services
 

in the areas of Oncology, Immunology, Infectious Diseases and novel preclinical models.

 
 
Send a request

eit HEALTH - European Union

eit Health

Progetto di ricerca e sviluppo “Messa a punto di metodi di produzione e purificazione di vettori di espressione per uso clinico: AAV, HSV-1, MVA e DNA - VECTOPUR”

Cofinanziamento dell’Unione Europea - FESR, PON Imprese e Competitività 2014-2020

CUP B88I17000100008

Progetto cofinanziato dall’Unione Europea, dallo Stato Italiano e dalla Regione Campania, nell’ambito del POR Campania FESR 2014 - 2020

Progetto "DALLA GENOMICA ALLA TERAPIA DI TUMORI RARI - CUP B61C17000060007"cofinanziato dall’Unione Europea, dallo Stato Italiano e dalla Regione Campania, nell’ambito del POR Campania FESR 2014 - 2020

Progetto cofinanziato dall’Unione Europea, dallo Stato Italiano e dalla Regione Campania, nell’ambito del POR Campania FESR 2014 - 2020
Menu
Our Services
Partners
Takis Biotech

Harnessing the Immune System to fight cancer.

 
 
 
Company
Takis S.r.l.

Via Castel Romano, 100
00128 Rome - Italy
P. I.V.A. 10700711004

 
 
Follow us
  • Terms of use
  • Privacy
  • Ethical code
  • Questo indirizzo email è protetto dagli spambots. È necessario abilitare JavaScript per vederlo.
  • Webmail